PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1382492-5	1992	After the addition of IFN-alpha, 17 of the 22 patients (77%) with elevated urinary 5-hydroxyindoleacetic acid showed a significant (> 50%) reduction.	Hydroxyindoleacetic Acid	83-109	interferon alpha 1	Homo sapiens	22-31	
1382492-9	1992	Thus, the addition of IFN-alpha is beneficial for patients with malignant carcinoid tumours that progress and/or who do not respond to octreotide.	Octreotide	135-145	interferon alpha 1	Homo sapiens	22-31